J C Lynn

Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.

K D Watenpaugh, W. Howe, D. Anderson, 1997, Journal of medicinal chemistry.

Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class.

K D Watenpaugh, K. Watenpaugh, R. Tommasi, 1998, Journal of medicinal chemistry.

Structure-based design of nonpeptidic HIV protease inhibitors from a cyclooctylpyranone lead structure.

K D Watenpaugh, W. Howe, K. Watenpaugh, 1995, Journal of medicinal chemistry.

Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors.

B C Finzel, K D Watenpaugh, W. Howe, 1996, Journal of medicinal chemistry.